Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Large-Cap Growth ETF
SCHG
|
+$2.6B |
| 2 |
Abbott
ABT
|
+$1.29B |
| 3 |
Home Depot
HD
|
+$1.03B |
| 4 |
Devon Energy
DVN
|
+$888M |
| 5 |
PepsiCo
PEP
|
+$880M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$1.6B |
| 2 |
Schwab Fundamental US Small Company Index ETF
FNDA
|
+$1.5B |
| 3 |
Schwab Fundamental US Large Company Index ETF
FNDX
|
+$1.34B |
| 4 |
Texas Instruments
TXN
|
+$1.32B |
| 5 |
Coterra Energy
CTRA
|
+$789M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.11% |
| 2 | Financials | 10.61% |
| 3 | Healthcare | 10.33% |
| 4 | Miscellaneous | 9.93% |
| 5 | Industrials | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2826
Distribution Solutions Group
DSGR
$1.62B
| $1.77M | ﹤0.01% |
64,728
+933
| +1% | +$25.5K |
2015 Q2
44 quarters
|
|
2827
Evommune Inc
EVMN
$220M
| $1.77M | ﹤0.01% |
133,072
+38,124
| +40% | +$886K |
2025 Q4
2 quarters
|
|
2828
Compass Diversified
CODI
$811M
| $1.77M | ﹤0.01% |
165,846
+20,575
| +14% | +$224K |
2020 Q1
25 quarters
|
|
2829
Enlight Renewable Energy
ENLT
$9.61B
| $1.77M | ﹤0.01% |
+19,856
| New | +$1.75M |
2026 Q2
0 quarters
|
|
2830
Peoples Financial Services
PFIS
$683M
| $1.76M | ﹤0.01% |
26,445
+2,346
| +10% | +$139K |
2014 Q2
48 quarters
|
|
2831
Atrium Therapeutics
RNA
$140M
| $1.75M | ﹤0.01% |
130,217
+13,619
| +12% | +$178K |
2026 Q1
1 quarter
|
|
2832
Northrim BanCorp
NRIM
$543M
| $1.75M | ﹤0.01% |
63,067
+5,724
| +10% | +$142K |
2023 Q2
12 quarters
|
|
2833
Accelerant Holdings
ARX
$4.29B
| $1.74M | ﹤0.01% |
+148,881
| New | +$2.09M |
2026 Q2
0 quarters
|
|
2834
Third Coast Bancshares
TCBX
$695M
| $1.74M | ﹤0.01% |
43,183
+9,046
| +26% | +$353K |
2021 Q4
18 quarters
|
|
2835
Patria Investments
PAX
$1.95B
| $1.74M | ﹤0.01% |
158,867
+14,640
| +10% | +$175K |
2023 Q2
12 quarters
|
|
2836
Coherus Oncology
CHRS
$159M
| $1.72M | ﹤0.01% |
1,228,069
+72,168
| +6% | +$118K |
2014 Q4
46 quarters
|
|
2837
Mayville Engineering Co
MEC
$384M
| $1.72M | ﹤0.01% |
45,861
+5,763
| +14% | +$154K |
2023 Q2
12 quarters
|
|
2838
Satellogic
SATL
$724M
| $1.7M | ﹤0.01% |
297,524
+52,854
| +22% | +$387K |
2025 Q2
4 quarters
|
|
2839
Keros Therapeutics
KROS
$230M
| $1.7M | ﹤0.01% |
158,712
-21,240
| -12% | -$237K |
2020 Q2
24 quarters
|
|
2840
SmartRent
SMRT
$220M
| $1.69M | ﹤0.01% |
1,423,357
+401,100
| +39% | +$509K |
2021 Q4
18 quarters
|
|
2841
Critical Metals Corp
CRML
$1B
| $1.69M | ﹤0.01% |
165,240
+37,054
| +29% | +$396K |
2024 Q2
8 quarters
|
|
2842
Seaport Entertainment Group
SEG
$285M
| $1.69M | ﹤0.01% |
63,587
+1,581
| +3% | +$37.2K |
2024 Q3
7 quarters
|
|
2843
Commerce.com Inc Series 1
CMRC
$289M
| $1.69M | ﹤0.01% |
570,023
+63,745
| +13% | +$183K |
2020 Q3
23 quarters
|
|
2844
The Elmet Group
ELMT
$625M
| $1.68M | ﹤0.01% |
+85,216
| New | +$1.46M |
2026 Q2
0 quarters
|
|
2845
NioCorp Developments
NB
$478M
| $1.68M | ﹤0.01% |
348,764
+90,496
| +35% | +$495K |
2025 Q2
4 quarters
|
|
2846
Civista Bancshares
CIVB
$555M
| $1.67M | ﹤0.01% |
59,304
+4,617
| +8% | +$117K |
2017 Q2
36 quarters
|
|
2847
Anika Therapeutics
ANIK
$274M
| $1.66M | ﹤0.01% |
113,374
-1,025
| -0.9% | -$15.2K |
2013 Q2
52 quarters
|
|
2848
Southern First Bancshares
SFST
$570M
| $1.66M | ﹤0.01% |
27,146
+5,071
| +23% | +$292K |
2016 Q2
40 quarters
|
|
2849
Resolute Holdings Management
RHLD
$929M
| $1.65M | ﹤0.01% |
11,441
-3,496
| -23% | -$454K |
2025 Q2
4 quarters
|
|
2850
Velocity Financial
VEL
$575M
| $1.65M | ﹤0.01% |
89,499
+4,099
| +5% | +$74.6K |
2021 Q2
20 quarters
|
|
Similar funds
Charles Schwab's Q2 2026 Portfolio in Review
As of Q2 2026, Charles Schwab held 3,591 positions worth $751B, up 15% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Charles Schwab's Q2 2026 filing shows 136 new, 2,145 increased, 1,132 reduced and 153 closed positions. Its largest new stake was Honeywell Aerospace: 2,031,187 shares worth $449M. The largest sale was Qualcomm, an estimated $1.6B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Charles Schwab's largest Q2 2026 buy was Honeywell Aerospace: 2,031,187 shares worth $449M.
- Charles Schwab added most to Schwab US Large-Cap Growth ETF in Q2 2026, an estimated $2.6B increase.
- Charles Schwab's biggest Q2 2026 reduction was Qualcomm, cutting an estimated $1.6B.
- Charles Schwab fully exited Coterra Energy in Q2 2026, selling an estimated $789M.
- Charles Schwab's ten largest holdings make up 22% of its $751B portfolio in Q2 2026.
- Charles Schwab opened 136 new positions and closed 153 in Q2 2026.
- Charles Schwab's portfolio value rose 15% quarter-over-quarter to $751B.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.